Case Reports in Oncological Medicine / 2015 / Article / Fig 2

Case Report

Rhabdomyosarcomatous Transformation of a Gastrointestinal Stromal Tumor following Treatment with Imatinib

Figure 2

Tumor at the time of en bloc resection. Left panels showing H&E (a, b) and immunophenotype of spindle cell component (a, c, e, g, and i) and right panels showing rhabdomyosarcomatous component (b, d, f, h, and j) as follows: (c, d) c-kit IHC, 200x, (e, f) DOG1 IHC, 200x, (g, h) desmin IHC, 200x, and (i, j) myoD-1, 400x.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)
(j)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.